Postoperative Pleural Effusions Management

Introduction to Postoperative Pleural Effusions

Postoperative pleural effusions require careful management, with colchicine not recommended in the absence of systemic inflammation, as stated by the European Society of Cardiology 1

Evaluation of post-pericardiotomy pleural effusions should distinguish between simple mechanical effusions and post-cardiac injury syndrome (PCIS), an inflammatory condition requiring specific treatment, according to the European Heart Society 1
Clinical assessment should evaluate for symptoms such as dyspnea, cough, tachypnea, and pain, and assess the need for increased respiratory support 2
Radiographic evaluation should include a chest radiograph to determine the size of the effusion (significant if >25-33% of hemithorax) and ultrasound to confirm and quantify the effusion 2

The European Society of Cardiology recommends NSAIDs or aspirin at full doses until symptom resolution, plus colchicine at a dose of 0.5 mg twice daily for patients ≥70 kg, or 0.5 mg once daily for patients <70 kg or intolerant to higher doses, for the treatment of post-cardiac injury syndrome 1
Low-dose corticosteroids (prednisone 0.25-0.5 mg/kg/day) can be used as second-line therapy if there are contraindications to NSAIDs/colchicine, as suggested by the European Heart Society 1
Ultrasound-guided thoracocentesis is recommended as the first-line intervention for large symptomatic effusions, reducing length of stay and improving recovery rates, according to the European Respiratory Journal 2
Therapeutic thoracentesis is preferred over surgical tube thoracostomy for effusions >400-480 mL or symptomatic smaller effusions, reducing length of stay and improving recovery rates 2

Treatment duration for post-cardiac injury syndrome should be guided by monitoring CRP levels and continued for an appropriate duration, such as 1 month, as stated by the European Heart Society 1
Recurrent effusions may require anti-inflammatory agents (NSAIDs, aspirin, colchicine, or glucocorticoids) for post-pericardiotomy syndrome, with colchicine having a preventive benefit when given postoperatively 2
Persistent effusions (>6 months) may require evaluation for trapped lung and surgical intervention (decortication) 2
The recurrence risk of effusions is approximately 21% despite intervention, emphasizing the need for vigilant follow-up 2

Risk factors for significant effusions include early chest drain removal, higher drain outputs before removal, and drain removal during or close to mechanical ventilation, highlighting the importance of careful drain management 2
CABG with internal mammary artery harvesting that preserves pleural integrity has lower rates of effusion development, suggesting a role for surgical technique in minimizing postoperative complications 2
Early removal of chest drains is associated with the development of pleural effusions, underscoring the importance of optimal drain management strategies 2

A dedicated follow-up protocol is recommended for patients with significant effusions, including consideration of repeat imaging if symptoms persist or worsen, and monitoring for complications such as renal impairment, pericardial effusion, need for ICU readmission, and reintubation 2